| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |



From the Departments of Critical Care Medicine, Medicine, and Community Health Sciences,* Faculty of Medicine, The University of Calgary, Calgary, Alberta; the
Canadian Council for Donation and Transplantation;
the Department of Neurology, Montreal Neurological Institute, McGill University, Montreal, Quebec; and the
Division of Critical Care Medicine, Department of Pediatrics, Montreal Childrens Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
Address correspondence to: Dr. Christopher James Doig, Associate Professor, Rm EG23G Foothills Medical Centre, 1403-29th Street NW, Calgary, Alberta T2N 2T9, Canada. Phone: 403-944-1691; Fax: 403-283-9994; E-mail: cdoig{at}ucalgary.ca
| Abstract |
|---|
|
|
|---|
Methods: An email survey of members of the Canadian Critical Care Society was undertaken. A survey instrument was developed, then face and content validated prior to distribution.
Results: Eighty eight responded (response rate = 49%), including adult and pediatric ICU physicians working in both tertiary referral (academic) and community hospitals. Most respondents admit patients with brain death to their ICUs. However, 9% reported refusing to admit this type of patient for reasons including inappropriate utilization of ICU resources (36%), and lack of either space or staff (32% and 29% of respondents, respectively). Community hospital-based ICU physicians were less likely to report a hospital policy on the determination of brain death (46% vs 78% of physicians in tertiary care hospitals). Nearly all physicians (96%) reported that a revised national standard and checklist for the determination of death would be useful.
Conclusions: Nearly one quarter, and over one half of tertiary care and community hospitals (respectively) in Canada lack an institutional policy on neurological determination of brain death. Canadian ICU physicians are interested in a national standard for the determination of death, and establishment of processes that may improve the clinical determination of death by neurological criteria.
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
The survey was developed by the authors for the sole purpose of this study, and conducted by Decima Research Inc. (Toronto, ON, Canada). Face and content validity were assessed by circulating the questionnaire to a select group of experts in the fields of neurosciences (n = 5), and survey design (n = 5) at the institution of the primary author. Comments on the syntax and structure of the questions were obtained from individuals at Decima Research Inc. who have considerable experience in conducting surveys of this type. Finally, the survey was field tested on a small sample (n = 10) of ICU physicians in the intended target population. Feedback on content and construction of questions was incorporated prior to distribution of the survey. Testing of the criterion and construct validity assessment of the survey were not undertaken. The survey development and study design did not include examining testing or variable-response reliability such as test-retest, inter-rater or internal consistency computations.
An administrative assistant independent of the research team was designated to receive all completed surveys, and stripped sender email addresses from the responses prior to forwarding the surveys for collation and analysis. Data are presented in the form of simple descriptive statistics.
| Results |
|---|
|
|
|---|
The survey responses are summarized in the Table
. Eighty-nine percent of respondents reported that patients presenting to their emergency department with severe brain injury and a poor anticipated neurological outcome are always, or usually admitted to the ICU for a trial of therapy and prognostication. Intensive care physicians caring for pediatric patients (86%) always admit patients with these presentations, compared to ICU physicians caring for adult patients who reported always, (20%) or usually (64%) admitting this type of patient. Nine percent of respondents reported that they had at least once refused admission or transfer of patients with severe brain injury and poor neurological outcome. The most common responses for refusing admission were: 1) inappropriate utilization of ICU resources - not otherwise defined (48%); 2) lack of physical bed space (20%); 3) lack of ICU staff (20%); 4) family declined admission (15%); and 5) patient not deemed a suitable candidate for organ donation (9%). Patients assessed in the emergency department and determined to be brain dead were reported as always admitted to ICU for the purpose of organ donation by 51% of respondents, and usually admitted, by 34% of respondents. The main reasons for not admitting a case of brain death to ICU were: 1) perceived inappropriate use of resources - not otherwise defined (36%); 2) lack of physical ICU bed space (32%); 3) lack of ICU staff (29%); 4) not a suitable candidate for organ donation (6%); and 5) admission declined by family (4%).
|
| Discussion |
|---|
|
|
|---|
This survey found that most physicians agree with the concept of a national non-legislated standard for the determination of brain death, and tools such as checklists of elements may help. Our survey did not ask why such checklists would be helpful: for example, to ensure the correct criteria were used, or to standardize documentation of the process used. However, previously published Canadian criteria for brain death may be applied inconsistently.6 This problem is not unique to Canada. In 1995, Mejia and Pollack reported the variability of practice in pediatric ICUs.7 Identified variations include a lack of apnea testing in 23% of cases, "controversial" apnea testing in 22% of cases, and other "contradictory" practices. Bell et al. recently conducted a survey in the United Kingdom of neurocritical care experts, and found similarly variable practices. 8 Finally, Keogh and Akhtar reported omissions in the documentation of the clinical criteria for brain death in medical notations in the chart. 9 In those centres which used checklists, clinical criteria omissions were significantly lower. These authors suggested that documentation on a checklist would be beneficial. Standardizing the processes (criteria and documentation) for determining brain death may be crucial to maintaining public confidence in these important medical decisions.
This survey was only intended to be descriptive, and there are several limitations which must be considered. The sampling frame identified only intensive care physicians who are members of the Canadian Critical Care Society. Use of a professional society is common surveying physician practices, although all physicians who work in Canadian ICUs may not be members of this society. Furthermore, this survey was limited by a response rate of only 49%. However, responses were received from all regions of the country, from physicians who practice in different clinical settings (i.e., community to tertiary-academic hospitals), from physicians who see different types of ICU patients (for example medical, surgical, neurocritical, and trauma), and from different sized ICUs. Although non-response is a potential bias of any survey, the diversity of clinical practice represented by these respondents decreases the likelihood of this type of systematic error affecting these study results. Finally, only the face and content validity of the survey was examined. However, as the purpose was only to describe certain attitudes in ICU physicians, and given the lack of data or prior hypotheses in this area, we felt that our approach to not proceed with construct or criterion testing was reasonable.
This survey does demonstrate variability in some processes of care in the determination of brain death, and the likelihood of admission to an ICU. Although our survey is limited by a response rate of 49% - albeit a response rate similar to other studies - there is reasonable support amongst ICU physicians for the development of a national standard for the neurological determination of death, and a standard process, such as by checklist, for documenting these clinical findings. A consensus conference to facilitate such a standard may help maintain and foster the publics confidence in the determination of death by neurologic criteria, and requests to families to consider organ donation.
| Footnotes |
|---|
Accepted for publication August 12, 2005. Revision accepted January 16, 2006. Final revision accepted January 17, 2006.
| References |
|---|
|
|
|---|
2 Wijdicks EF. Brain death worldwide: accepted fact but no global consensus in diagnostic criteria. Neurology 2002; 58: 20–5.
3 Anonymous. Death and brain death: a new formulation for Canadian medicine. Canadian Congress Committee on Brain Death. CMAJ 1988; 138: 405–6.[Medline]
4 Anonymous. Guidelines for the diagnosis of brain death. Canadian Neurocritical Care Group. Can J Neurol Sci 1999; 26: 64–6.[Medline]
5 Hazony O. Increasing the supply of cadaver organs for transplantation: recognizing that the real problem is psychological not legal. Health Matrix Clevel 1993; 3: 219–57.[Medline]
6 Shemie S, Teitelbaum J, Doig C. Variability in hospital-based brain death guidelines in Canada. Can J Anesth 2006; 53: 613–19.
7 Mejia RE, Pollack MM. Variability in brain death determination practices in children. JAMA 1995; 274: 550–3.[Abstract]
8 Bell MD, Moss E, Murphy PG. Brainstem death testing in the UK—time for reappraisal? Br J Anaesth 2004; 92: 633–40.
9 Keogh AT, Akhtar TM. Diagnosing brain death: the importance of documenting clinical test results. Anaesthesia 1999; 54: 81–5.[Medline]
This article has been cited by other articles:
![]() |
D. J. Doyle Must the entire brain be dead to diagnose brain death? Can J Anesth, October 1, 2006; 53(10): 1061 - 1061. [Full Text] [PDF] |
||||
![]() |
S. D. Shemie Brain arrest to neurological determination of death to organ utilization: the evolution of hospital-based organ donation strategies in Canada/De l'arret cerebral a la determination neurologique de la mort et a l'utilisation d'organes : l'evolution du don d'organes en milieu hospitalier au Canada. Can J Anesth, August 1, 2006; 53(8): 747 - 752. [Full Text] [PDF] |
||||
![]() |
E. F. M. Wijdicks The clinical criteria of brain death throughout the world: why has it come to this?/Les criteres cliniques de mort encephalique a travers le monde : pourquoi en arriver la ? Can J Anesth, June 1, 2006; 53(6): 540 - 543. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |